These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 11833160)

  • 21. WTO: US and Argentina settle dispute over patents and data protection.
    Elliott R
    Can HIV AIDS Policy Law Rev; 2002 Dec; 7(2-3):65. PubMed ID: 14743805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patent implications in the pharmaceutical industry: Are static high prices leading to dynamic innovations?
    Pandey E; Paul SB
    Int J Risk Saf Med; 2019; 30(3):179-192. PubMed ID: 31450515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent developments in health law. India's evolving patent laws and WTO obligations: the rejection of Abbott Laboratories' application for a new Kaletra patent.
    Chilton A
    J Law Med Ethics; 2011; 39(2):296-300. PubMed ID: 21710799
    [No Abstract]   [Full Text] [Related]  

  • 24. A one-time-only combination: Emergency medicine exports and the TRIPS agreement under Canada's access to medicines regime.
    Weber A; Mills L
    Health Hum Rights; 2010 Jun; 12(1):109-22. PubMed ID: 20930258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Canada and access to medicines in developing countries: intellectual property rights first.
    Lexchin J
    Global Health; 2013 Sep; 9():42. PubMed ID: 24007595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Court orders development of evidence before ruling on patent.
    AIDS Policy Law; 2003 Jun; 18(11):7. PubMed ID: 12866470
    [No Abstract]   [Full Text] [Related]  

  • 27. The WTO dispute settlement understanding: an unlikely weapon in the fight against AIDS.
    Curti AM
    Am J Law Med; 2001; 27(4):469-85. PubMed ID: 11837145
    [No Abstract]   [Full Text] [Related]  

  • 28. TRIPS from Doha to Cancún ... to Ottawa: global developments in access to treatment and Canada's Bill C-56.
    Elliott R
    Can HIV AIDS Policy Law Rev; 2003 Dec; 8(3):1, 7-18. PubMed ID: 15104062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. International trade regulation and publicly funded health care in Canada.
    Ostry AS
    Int J Health Serv; 2001; 31(3):475-80. PubMed ID: 11562000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amendments to the Canadian Patent Act to address drug access: is help on the way?
    Penner MD; Narayanan P
    Food Drug Law J; 2005; 60(3):459-70. PubMed ID: 16304751
    [No Abstract]   [Full Text] [Related]  

  • 31. Canada's laws on pharmaceutical intellectual property: the case for fundamental reform.
    Grootendorst P; Bouchard R; Hollis A
    CMAJ; 2012 Mar; 184(5):543-9. PubMed ID: 22065362
    [No Abstract]   [Full Text] [Related]  

  • 32. Proposed trade agreement could increase patent protection for pharmaceuticals.
    Eggertson L
    CMAJ; 2013 Jul; 185(10):E459-60. PubMed ID: 23695601
    [No Abstract]   [Full Text] [Related]  

  • 33. Impact on access to medicines from TRIPS-Plus: a case study of Thai-US FTA.
    Kessomboon N; Limpananont J; Kulsomboon V; Maleewong U; Eksaengsri A; Paothong P
    Southeast Asian J Trop Med Public Health; 2010 May; 41(3):667-77. PubMed ID: 20578557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pills, patents, and power: state creation of gray markets as a limit on patent rights.
    Ghosh S
    Fla J Int Law; 2002; 14(2):217-60. PubMed ID: 16526138
    [No Abstract]   [Full Text] [Related]  

  • 35. Canada files WTO complaint against EC.
    Can HIV AIDS Policy Law Rev; 2000; 5(4):29. PubMed ID: 11833163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intellectual property rights, the World Trade Organization and public health: the Brazilian perspective.
    Viana JM
    Conn J Int Law; 2002; 17(2):311-8. PubMed ID: 12688298
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmaceutical patent law: the Canadian perspective.
    Aumand L; Norman J
    Pharm Pat Anal; 2016 Jul; 5(4):271-9. PubMed ID: 27346187
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Canada to change patent law to allow export of cheap drugs.
    Kondro W
    Lancet; 2003 Oct; 362(9392):1290. PubMed ID: 14577437
    [No Abstract]   [Full Text] [Related]  

  • 39. How do public health safeguards in Indian patent law affect pharmaceutical patenting in practice?
    Sampat BN; Amin T
    J Health Polit Policy Law; 2013 Aug; 38(4):735-55. PubMed ID: 23645877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cambodia's Imminent Graduation from Least Developed Country Status: What Will be the Impact of the TRIPS Agreement on Access to HIV and Hepatitis C Medicines in Cambodia?
    Tenni B; Lexchin J; Phin S; Gleeson D
    Int J Soc Determinants Health Health Serv; 2024 Jul; 54(3):295-308. PubMed ID: 38563076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.